PDF) New insights in systemic lupus erythematosus: From regulatory T cells to CAR-T-cell strategies
TSI test
Untitled
PDF) Post-translational structural modifications of immunoglobulin G and their effect on biological activity
Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer Treatment | Journal of Medicinal Chemistry